Lake Charles D II, who holds the positions of chairman and representative director at Aflac Inc. (NYSE: AFL), executed a sale of 15,590 shares of the company's common stock on March 11, 2026, at $109.93 per share, a Form 4 filed with the Securities and Exchange Commission shows. The proceeds from the trade totaled $1,713,808.
Following the disposition, Lake Charles D II now directly holds 62,237 shares of Aflac common stock. In addition to the direct holdings, the reporting owner indirectly owns 1,327 shares through a 401(k) plan, as noted in the filing.
The shares sold were transacted under a Rule 10b5-1 trading plan that was adopted on December 8, 2025. The Form 4 filing records the trade but does not provide commentary on the motivation behind the sale.
Context from recent company results
In its fourth-quarter 2025 financials, Aflac reported a mixed set of outcomes. The insurer recorded earnings per share of $1.57, missing consensus expectations of $1.70 - a shortfall of 7.65 percent. On the top line, Aflac reported revenue of $4.87 billion, exceeding the anticipated $4.28 billion and representing a positive surprise of 13.79 percent versus forecasts.
Corporate updates also include analyst adjustments to valuation and recommendations. Mizuho raised its price target on Aflac to $107.00 from $104.00, while retaining an Underperform rating. The firm’s revised target reflects a valuation roll-forward, and its outlook implies an expected negative return of approximately 6 percent for the stock.
Dividend and valuation notes
Separately, Aflac has a long record of returning cash to shareholders, having raised its dividend for 42 consecutive years and offering a current yield of 2.23 percent. Available valuation commentary indicates the stock is trading near what is considered fair value.
What this means for investors
The filing documents the insider sale and the current ownership position of the chairman and representative director. It also places that transaction against a backdrop of recent quarterly results that were mixed, and an analyst view that maintains an Underperform stance even as the price target was modestly increased.
Investors monitoring Aflac should note the disclosed share sale, the company’s recent earnings and revenue figures, the long dividend increase streak and current yield, and the most recent analyst valuation move.